The intricate mechanisms of neurodegeneration in prion diseases.

[1]  G. Taglialatela,et al.  Calcineurin Inhibition at the Clinical Phase of Prion Disease Reduces Neurodegeneration, Improves Behavioral Alterations and Increases Animal Survival , 2010, PLoS pathogens.

[2]  A. Aguzzi,et al.  Supplementary figure legends , 2010 .

[3]  C. Soto,et al.  Generation of prions in vitro and the protein-only hypothesis , 2010, Prion.

[4]  D. Rubinsztein,et al.  Cytoprotective roles for autophagy , 2010, Current opinion in cell biology.

[5]  Ronald Melki,et al.  Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.

[6]  J. Moreno,et al.  Dysfunction and recovery of synapses in prion disease: implications for neurodegeneration. , 2010, Biochemical Society transactions.

[7]  B. Chesebro,et al.  Fatal Transmissible Amyloid Encephalopathy: A New Type of Prion Disease Associated with Lack of Prion Protein Membrane Anchoring , 2010, PLoS pathogens.

[8]  Frank Baumann,et al.  Axonal prion protein is required for peripheral myelin maintenance , 2010, Nature Neuroscience.

[9]  M. Diamond,et al.  Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.

[10]  G. Fimia,et al.  Regulation of autophagy in mammals and its interplay with apoptosis , 2010, Cellular and Molecular Life Sciences.

[11]  M. Gobbi,et al.  Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein , 2010, Proceedings of the National Academy of Sciences.

[12]  Adriano Aguzzi,et al.  Prions: protein aggregation and infectious diseases. , 2009, Physiological reviews.

[13]  G. Mallucci.  Prion neurodegeneration , 2009, Prion.

[14]  V. Perry,et al.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. , 2009, The American journal of pathology.

[15]  Jin-A. Lee.  Autophagy in neurodegeneration: two sides of the same coin. , 2009, BMB reports.

[16]  H. Schätzl,et al.  Lithium induces clearance of protease resistant prion protein in prion‐infected cells by induction of autophagy , 2009, Journal of neurochemistry.

[17]  H. Schätzl,et al.  Autophagy induction by trehalose counter-acts cellular prion-infection , 2009, Autophagy.

[18]  Inyoul Y. Lee,et al.  A systems approach to prion disease , 2009, Molecular systems biology.

[19]  D. Harris,et al.  Fishing for Prion Protein Function , 2009, PLoS biology.

[20]  A. Sakudo,et al.  Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein. , 2009, Protein and peptide letters.

[21]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[22]  M. Mohan,et al.  Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis , 2009, PloS one.

[23]  John Calvin Reed,et al.  Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities , 2008, Nature Reviews Drug Discovery.

[24]  Shannon L Bartelt-Hunt,et al.  Prions in the environment , 2008, Prion.

[25]  R. Hegde,et al.  Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. , 2008, Developmental cell.

[26]  S. Prusiner,et al.  A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains , 2008, Proceedings of the National Academy of Sciences.

[27]  B. Caughey,et al.  Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). , 2008, Folia neuropathologica.

[28]  H. Budka,et al.  Prion diseases: from protein to cell pathology. , 2008, The American journal of pathology.

[29]  P. Walter,et al.  Endoplasmic reticulum stress in disease pathogenesis. , 2008, Annual review of pathology.

[30]  R. Kaufman,et al.  The endoplasmic reticulum and the unfolded protein response. , 2007, Seminars in cell & developmental biology.

[31]  Andrew D. Steele,et al.  Diminishing Apoptosis by Deletion of Bax or Overexpression of Bcl-2 Does Not Protect against Infectious Prion Toxicity In Vivo , 2007, The Journal of Neuroscience.

[32]  A. Aguzzi,et al.  Bcl‐2 overexpression delays caspase‐3 activation and rescues cerebellar degeneration in prion‐deficient mice that overexpress amino‐terminally truncated prion , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  T. Kingsbury,et al.  Calcineurin activity is required for depolarization‐induced, CREB‐dependent gene transcription in cortical neurons , 2007, Journal of neurochemistry.

[34]  Andrew D. Steele,et al.  Prion Pathogenesis is Independent of Caspase-12 , 2007, Prion.

[35]  J. Grosclaude,et al.  In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers , 2007, PLoS pathogens.

[36]  B. Chesebro,et al.  Prion Protein Expression Differences in Microglia and Astroglia Influence Scrapie-Induced Neurodegeneration in the Retina and Brain of Transgenic Mice , 2007, Journal of Virology.

[37]  Jochen Herms,et al.  Dendritic Pathology in Prion Disease Starts at the Synaptic Spine , 2007, The Journal of Neuroscience.

[38]  D. Harris,et al.  The cellular prion protein (PrP(C)): its physiological function and role in disease. , 2007, Biochimica et biophysica acta.

[39]  K. Abid,et al.  The prion strain phenomenon: molecular basis and unprecedented features. , 2007, Biochimica et biophysica acta.

[40]  C. Soto.  Reversibility of prion-induced neurodegeneration , 2007, The Lancet Neurology.

[41]  B. Ghetti,et al.  Accumulation of prion protein in the brain that is not associated with transmissible disease , 2007, Proceedings of the National Academy of Sciences.

[42]  J. Collinge,et al.  Targeting Cellular Prion Protein Reverses Early Cognitive Deficits and Neurophysiological Dysfunction in Prion-Infected Mice , 2007, Neuron.

[43]  R. Chiesa,et al.  Conditions of Endoplasmic Reticulum Stress Favor the Accumulation of Cytosolic Prion Protein* , 2006, Journal of Biological Chemistry.

[44]  S. Messiaen,et al.  Bax deletion does not protect neurons from BSE-induced death , 2006, Neurobiology of Disease.

[45]  A. Kanthasamy,et al.  Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. , 2006, Neurotoxicology.

[46]  Thomas H. Gillingwater,et al.  Synaptic Vulnerability in Neurodegenerative Disease , 2006, Journal of neuropathology and experimental neurology.

[47]  K. Roth,et al.  Prion protein protects against ethanol-induced Bax-mediated cell death in vivo , 2006, Neuroreport.

[48]  H. True,et al.  New Insights into Prion Structure and Toxicity , 2006, Neuron.

[49]  Junying Yuan,et al.  Cellular response to endoplasmic reticulum stress: a matter of life or death , 2006, Cell Death and Differentiation.

[50]  C. Hetz,et al.  Stressing out the ER: a role of the unfolded protein response in prion-related disorders. , 2006, Current molecular medicine.

[51]  E. Walter,et al.  The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4. , 2005, Journal of the American Chemical Society.

[52]  E. Masliah,et al.  Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie , 2005, Science.

[53]  K. Kaneko,et al.  Prion protein with Y145STOP mutation induces mitochondria-mediated apoptosis and PrP-containing deposits in vitro. , 2005, Biochemical and biophysical research communications.

[54]  S. Prusiner,et al.  Notch-1 activation and dendritic atrophy in prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. Ghetti,et al.  Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Aguzzi,et al.  Modulation of signal transduction through the cellular prion protein is linked to its incorporation in lipid rafts , 2004, Cellular and Molecular Life Sciences CMLS.

[57]  P. Liberski,et al.  Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy. , 2004, The international journal of biochemistry & cell biology.

[58]  C. Hetz,et al.  Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. , 2004, The American journal of pathology.

[59]  M. Burwinkel,et al.  Role of cytokines and chemokines in prion infections of the central nervous system , 2004, International Journal of Developmental Neuroscience.

[60]  Neil R. Cashman,et al.  Prion diseases — close to effective therapy? , 2004, Nature Reviews Drug Discovery.

[61]  H. Ralston,et al.  The Neurodegeneration Sequence in Prion Diseases: Evidence from Functional, Morphological and Ultrastructural Studies of the GABAergic System , 2004, Journal of neuropathology and experimental neurology.

[62]  M. Otto,et al.  Role of interleukin-1 in prion disease-associated astrocyte activation. , 2004, The American journal of pathology.

[63]  J. Castilla,et al.  The controversial protein-only hypothesis of prion propagation , 2004, Nature Medicine.

[64]  M. Michalak,et al.  Calreticulin, Ca2+, and calcineurin - signaling from the endoplasmic reticulum. , 2004, Molecules and cells.

[65]  Fred E. Cohen,et al.  Evidence for assembly of prions with left-handed β-helices into trimers , 2004 .

[66]  B. Volpe,et al.  Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo , 2004, Science.

[67]  Alexei Degterev,et al.  A decade of caspases , 2003, Oncogene.

[68]  Sebastian Brandner,et al.  Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.

[69]  J. Castilla,et al.  Caspase‐12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein , 2003, The EMBO journal.

[70]  A. Verkhratsky,et al.  Endoplasmic reticulum Ca2+ homeostasis and neuronal death , 2003, Journal of cellular and molecular medicine.

[71]  H. Budka.  Neuropathology of prion diseases. , 2003, British medical bulletin.

[72]  C. Hetz,et al.  Is loss of function of the prion protein the cause of prion disorders? , 2003, Trends in molecular medicine.

[73]  C. Hetz,et al.  Prion Protein Misfolding and Brain Degeneration , 2003 .

[74]  V. Perry,et al.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.

[75]  P. Agostinho,et al.  Involvement of calcineurin in the neurotoxic effects induced by amyloid‐beta and prion peptides , 2003, The European journal of neuroscience.

[76]  R. Veerhuis,et al.  Neuroinflammation in Alzheimer's disease and prion disease , 2002, Glia.

[77]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[78]  S. Lindquist,et al.  Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol , 2002, Science.

[79]  J. Langeveld,et al.  Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation , 2002, Neuroreport.

[80]  A. Burlingame,et al.  Stress‐inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection , 2002, The EMBO journal.

[81]  R. Linden,et al.  Cellular prion protein transduces neuroprotective signals , 2002, The EMBO journal.

[82]  C. Cunningham,et al.  Atypical inflammation in the central nervous system in prion disease , 2002, Current opinion in neurology.

[83]  P. Lantos,et al.  Quantification of vacuolation (‘spongiform change’), surviving neurones and prion protein deposition in eleven cases of variant Creutzfeldt–Jakob disease , 2002, Neuropathology and applied neurobiology.

[84]  S. Haswell,et al.  Metal imbalance and compromised antioxidant function are early changes in prion disease. , 2002, The Biochemical journal.

[85]  S. Ratté,et al.  Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration , 2002, The EMBO journal.

[86]  J. Fraser,et al.  What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired? , 2002, Neuropathology and applied neurobiology.

[87]  T. Cotter,et al.  Prion Protein Fragment PrP-(106–126) Induces Apoptosis via Mitochondrial Disruption in Human Neuronal SH-SY5Y Cells* , 2001, The Journal of Biological Chemistry.

[88]  D. R. Brown.  Copper and prion diseases. , 2001, Biochemical Society transactions.

[89]  David R. Brown,et al.  Microglia and prion disease , 2001, Microscopy research and technique.

[90]  S. Hornemann,et al.  Prion Protein Binds Copper within the Physiological Concentration Range* , 2001, The Journal of Biological Chemistry.

[91]  J. Vincent,et al.  In Vivo Cytotoxicity of the Prion Protein Fragment 106–126* , 2000, The Journal of Biological Chemistry.

[92]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[93]  Y. Bailly,et al.  Synaptic prion protein immuno‐reactivity in the rodent cerebellum , 2000, Microscopy research and technique.

[94]  J. Fournier,et al.  Ultrastructural localization of prion proteins: Physiological and pathological implications , 2000 .

[95]  B. Puig,et al.  Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt–Jakob disease , 2000, Neuroscience.

[96]  L. Adorini,et al.  Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. , 2000, Immunology today.

[97]  Patrick Couvreur,et al.  Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis , 2000, The Journal of pathology.

[98]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[99]  A. Johnston,et al.  Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus , 2000, Neuropathology and applied neurobiology.

[100]  V. Perry,et al.  Vacuolation in murine prion disease: an informative artifact , 1999, Current Biology.

[101]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[102]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[103]  A. Aguzzi,et al.  Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[104]  M. Salmona,et al.  Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels , 1999, Brain Research.

[105]  David R. Brown,et al.  Cellular uptake of the prion protein fragment PrP106-126 in vitro , 1999, Journal of neurocytology.

[106]  S. Prusiner,et al.  A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.

[107]  L. Mucke,et al.  Astrocyte‐specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie , 1997, The EMBO journal.

[108]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[109]  P. Lucassen,et al.  PrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie , 1997, Experimental Neurology.

[110]  J. Rossier,et al.  Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.

[111]  G. Forloni,et al.  Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. , 1996, Biochemical and biophysical research communications.

[112]  V. Perry,et al.  EVIDENCE FOR AN EARLY INFLAMMATORY RESPONSE IN THE CENTRAL NERVOUS SYSTEM OF MICE WITH SCRAPIE , 1996, Neuroscience.

[113]  B. Ghetti,et al.  Prion Protein Amyloidosis , 1996, Brain pathology.

[114]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[115]  A. Aguzzi,et al.  Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.

[116]  L. Mucke,et al.  Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent , 1995, Neuron.

[117]  T. Billette de Villemeur,et al.  Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. , 1995, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[118]  H. Fraser,et al.  Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice , 1994, Brain Research.

[119]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[120]  V. Perry,et al.  Characterization of the microglial response in murine scrapie , 1994, Neuropathology and applied neurobiology.

[121]  W. Engel,et al.  Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions , 1993, Neuroscience Letters.

[122]  R. Shin,et al.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. , 1992, The American journal of pathology.

[123]  Marsh Rf,et al.  Transmissible mink encephalopathy. , 1992, Revue scientifique et technique.

[124]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[125]  J. Lowe,et al.  Lysosomes as key organelles in the pathogenesis of prion encephalopathies , 1992, The Journal of pathology.

[126]  Hanson Rp,et al.  Transmissible mink encephalopathy. Reduced spongiform degeneration in aged mink of the Chediak-Higashi genotype. , 1976 .

[127]  N. Mizushima.  Physiological functions of autophagy. , 2009, Current topics in microbiology and immunology.

[128]  A. Aguzzi,et al.  Approaches to therapy of prion diseases. , 2005, Annual review of medicine.

[129]  X. Roucou,et al.  Cellular prion protein neuroprotective function: implications in prion diseases , 2004, Journal of Molecular Medicine.

[130]  H. Fraser,et al.  Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae , 2004, Acta Neuropathologica.

[131]  P. Liberski.  Spongiform change--an electron microscopic view. , 2004, Folia neuropathologica.

[132]  Claudio Soto,et al.  Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.

[133]  C. Hetz,et al.  Protein misfolding and disease: the case of prion disorders , 2003, Cellular and Molecular Life Sciences CMLS.

[134]  N. Hunter,et al.  Partial dissociation of PrP(Sc) deposition and vacuolation in the brains of scrapie and BSE experimentally affected goats. , 2001, The Journal of general virology.

[135]  西田教行.  Prion Protein is Necessary for Latent Learning and Long-Term Memory Retention , 1997 .

[136]  R. Marsh,et al.  Transmissible mink encephalopathy. Reduced spongiform degeneration in aged mink of the Chediak-Higashi genotype. , 1976, Laboratory investigation; a journal of technical methods and pathology.